Mandarin Oriental, Inc. v. HDI Global Insurance Company

CourtDistrict Court, S.D. New York
DecidedJune 10, 2025
Docket1:23-cv-04951
StatusUnknown

This text of Mandarin Oriental, Inc. v. HDI Global Insurance Company (Mandarin Oriental, Inc. v. HDI Global Insurance Company) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mandarin Oriental, Inc. v. HDI Global Insurance Company, (S.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK MANDARIN ORIENTAL, INC. Plaintiff, v. CIVIL ACTION NO. 23 Civ. 4951 (JPC) (SLC)

HDI GLOBAL INSURANCE COMPANY and ASSICURAZIONI GENERALI S.p.A., OPINION & ORDER

Defendant.

SARAH L. CAVE, United States Magistrate Judge.

I.INTRODUCTION In this insurance coverage dispute arising out of the COVID-19 pandemic, now before the Court is the motion of Plaintiff Mandarin Oriental, Inc. (“Mandarin”) to compel two of its insurers, Defendants HDI Global Insurance Company (“HDI”) and Assicurazioni Generali S.p.A. (“Generali”, with HDI, “Defendants”) to produce certain documents Defendants have withheld as privileged. (ECF No. 59 (the “Motion”)). Following an in camera review of ten exemplar documents (the “Exemplars”), and a conference with the parties, and for the reasons set forth below, the Motion is GRANTED IN PART and DENIED IN PART. II.BACKGROUND The factual and procedural background of this action is set forth in the Opinion and Order the Honorable John P. Cronan issued on September 19, 2024 denying Defendants’ motion to dismiss Mandarin’s breach of contract claim (Count II) and sua sponte dismissing Mandarin’s declaratory judgment claim (Count I). See Mandarin Oriental, Inc. v. HDI Global Ins. Co., No. 23 Civ. 4951 (JPC), 2024 WL 4252562, at *1–2 (S.D.N.Y. Sept. 19, 2024). We incorporate that background by reference, continue the use of defined terms, and set forth only the additional background necessary to decide the Motion. A. Factual Background Mandarin operates, as is relevant here, hotels in Miami, New York, Washington, DC, and Boston (the “Hotels”). (ECF No. 1 ¶ 2). “Mandarin purchased ‘all risks’ commercial lines

insurance policies from a group of insurers that included HDI and Generali, under which the insurers had quota share percentages of coverage.” Mandarin Oriental, 2024 WL 4252562, at *1.1 The coverage period under the HDI policy was May 1, 2018 until May 1, 2020, and under 0F the Generali policy was May 1, 2016 through May 1, 2021 (the HDI policy and the Generali policy together, the “Policies”). Id. “Both [P]olicies contained Endorsement No. 3, which provided coverage for certain special perils[,]” including “loss resulting from interruption of or interference with the business carried on by [Mandarin] in consequence of: (a) Infectious or contagious disease manifested by any person while on the premises of [Mandarin] or within a radius of 5 miles thereof.” Id. (quoting ECF No. 1 ¶ 16). Endorsement No. 3 required Mandarin to file any claim for coverage within: such length of time as would be required with the exercise of due diligence and dispatch to restore [its] business to the condition that would have existed had no loss occurred and shall include the time required to make the premises conform to the order of a competent public authority, subject to any Period of Recovery stipulated in the policy and beginning with the interruption or interference with the business.

Id. (quoting ECF No. 1 ¶ 17). “Endorsement No. 3 has a $10 million per occurrence sublimit, which Mandarin contends ‘separately applies at each of Mandarin’s four separate hotel premises.’” Id. (quoting ECF No. 1 ¶ 17).

1 Internal citations and quotation marks are omitted from case citations unless otherwise indicated. In this action, Mandarin alleges that the Hotels “were impacted by the COVID-19 pandemic and the attendant manifestations of COVID-19 by any person within a 5-mile radius of each of those hotels.” (ECF No. 1 ¶ 25). “The first COVID-19 manifestation in someone within a

five-mile radius of each of those hotels occurred between February and March 2020, depending on the hotel.” Mandarin, 2024 WL 4252562, at *2. Mandarin claims to have suffered tens of millions of dollars in business interruption losses at the Hotels due to COVID-19. Id. (See ECF Nos. 1 ¶¶ 30–34; 59 at 1). Mandarin seeks to hold HDI and Generali liable under the Policies for their respective 25% and 10% shares of the $10 million sublimit for each occurrence. (ECF No. 59

at 1). On March 24, 2020, Mandarin first notified Defendants that it was asserting claims under the Policies for the business interruption losses at the Hotels. (ECF Nos. 1 ¶ 36; 59 at 1; 62 at 1). To adjust Mandarin’s claims, Defendants hired McLarens as an independent adjuster and J.S. Held as a forensic accountant. (ECF No. 62 at 1). Defendants contend that fact discovery has shown that McLarens and J.S. Held collected and analyzed factual data, and Zelle LLP (“Zelle”) was

counsel for and provided legal advice to Defendants. (Id.) On June 1, 2020, Defendants issued—through McLarens—notifying Mandarin that they planned to “investigate th[e] claim under a full reservation of rights[.]” (ECF No. 62-3 at 2). Throughout 2020, the parties corresponded about Mandarin’s claims, with Defendants making several information requests, to which Mandarin responded. (ECF Nos. 1 ¶¶ 37, 43; 59 at 1). The parties dispute whether Mandarin’s responses were sufficient. (Compare ECF No. 59 at 1 with

ECF No. 62 at 1–2; see ECF No. 67). To date, Defendants have not provided Mandarin with a formal coverage opinion (outside the mediation context), (ECF No. 59 at 2), but have “set reserves . . . based on legal advice regarding potential exposure[.]” (ECF No. 62 at 2). B. Procedural Background

After denying Defendants’ motion to dismiss, see Mandarin Oriental, 2024 WL 4252562, Judge Cronan referred the matter to the undersigned for general pretrial supervision, and the parties began fact discovery, with a deadline of May 30, 2025, later extended to June 30, 2025. (ECF Nos. 38; 46; 58). During discovery, Defendants withheld from production as privileged approximately 500 documents, which they recorded on four privilege logs, one each for Generali,

HDI, McLarens, and J.S. Held. (ECF No. 67 at 6; see ECF Nos. 59-3; 59-4; 59-5; 59-6). Following a conference with the parties on April 7, 2025, during which Mandarin indicated its intent to seek to compel Defendants to produce certain documents they withheld as privileged, the Court ordered the parties to meet and confer to identify the Exemplars and set a briefing schedule for the Motion. (ECF No. 58). On April 18, 2025, Mandarin filed the Motion, on April 25, 2025, Defendants filed an opposition, and on April 30, 2025, Mandarin filed a reply. (ECF

Nos. 59; 62; 64). On May 21, 2025, the Court held a conference with the parties to discuss the Motion (ECF No. 63; see ECF min. entry dated May 21, 2025), following which, at the Court’s direction, Defendants provided the Court with translations of foreign language portions of the Exemplars. (See ECF No. 67 at 26–27). III.DISCUSSION A. Legal Standards 1. Federal Rule of Civil Procedure 26

Federal Rule of Civil Procedure 26 permits a party to “obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the importance of discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs

its likely benefit.” Fed. R. Civ. P. 26(b)(1). “Although not unlimited, relevance, for purposes of discovery, is an extremely broad concept.” Condit v. Dunne, 225 F.R.D. 100, 105 (S.D.N.Y. 2004).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Upjohn Co. v. United States
449 U.S. 383 (Supreme Court, 1981)
In Re Grand Jury Subpoenas Dated Dec. 18, 1981, Etc.
561 F. Supp. 1247 (E.D. New York, 1982)
Denney v. Jenkens & Gilchrist
362 F. Supp. 2d 407 (S.D. New York, 2004)
United States v. United Shoe MacHinery Corporation
89 F. Supp. 357 (D. Massachusetts, 1950)
Schaeffler v. United States
806 F.3d 34 (Second Circuit, 2015)
Spectrum Systems International v. Chemical Bank
581 N.E.2d 1055 (New York Court of Appeals, 1991)
Brooklyn Union Gas Co. v. American Home Assurance Co.
23 A.D.3d 190 (Appellate Division of the Supreme Court of New York, 2005)
Koumoulis v. Independent Financial Marketing Group, Inc.
29 F. Supp. 3d 142 (E.D. New York, 2014)
Viacom, Inc. v. Sumitomo Corp.
200 F.R.D. 213 (S.D. New York, 2001)
Aktiebolag v. Andrx Pharmaceuticals, Inc.
208 F.R.D. 92 (S.D. New York, 2002)
Bank of America, N.A. v. Terra Nova Insurance
212 F.R.D. 166 (S.D. New York, 2002)
Condit v. Dunne
225 F.R.D. 100 (S.D. New York, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Mandarin Oriental, Inc. v. HDI Global Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mandarin-oriental-inc-v-hdi-global-insurance-company-nysd-2025.